Will Hims & Hers Health (HIMS) stock recover?
What do analysts say about HIMS?
Average price target from 10 analysts: $33 over ~12 months (Hold consensus), i.e. +9 % from the current price. Most reliable firm on HIMS: TD Cowen (100% hit rate, 4 scored calls). A target is a 12-month view, not for tomorrow.
What happened after its past drops?
Over 2019-2026, Hims & Hers Health saw 5 drops of 30%+. Twelve months later it was -30 % on median (positive 40% of the time). It regained its pre-crash high in 60% of cases, in about 3 months. (monthly history 2019-2026 — transparency data, not a guarantee)
HIMS's biggest months
⚠️ Drop measured from the 12-month high; analyst targets on a ~12-month horizon; monthly history since 2013. Information, not investment advice. Past performance does not guarantee future results.
Frequently asked questions
Will Hims & Hers Health stock recover?
No one can guarantee it, and we won't. What we know: it's down 47 % from its high; analysts target $33 over 12 months (+9 % from the current price). Over 2019-2026, Hims & Hers Health saw 5 drops of 30%+. Twelve months later it was -30 % on median (positive 40% of the time). It regained its pre-crash high in 60% of cases, in about 3 months. Past performance does not guarantee future results.
Why has HIMS dropped so much?
We don't assert the cause of a drop — a headline can be a consequence or a coincidence. What we measure is what comes next: the analysts' target and the stock's historical behavior after this kind of drop.
Should I buy HIMS now that it's down?
A drop is not a buy signal by itself. Cross-check with the analysts' target, their real reliability on the stock (most solid: TD Cowen, 100% hit rate), and the fundamentals. This is not personalized advice.